<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We determined using serial <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> imaging whether raised plasma <z:chebi fb="0" ids="17230">homocysteine</z:chebi> levels are associated with increased brain <z:mpath ids='MPATH_127'>atrophy</z:mpath>, white matter lesion (WML) progression or incidence of silent brain <z:mpath ids='MPATH_124'>infarcts</z:mpath> (SBIs) in older hypertensive subjects </plain></SENT>
<SENT sid="1" pm="."><plain>Brain <z:mpath ids='MPATH_127'>atrophy</z:mpath> rates (0.58 ± 0.48% per year, mean ± SD) were significantly correlated with <z:chebi fb="0" ids="17230">homocysteine</z:chebi> (β = 0.46, p = 0.001 homocysteine; β = 0.44, p = 0.007 homocysteine/folate/B12 models) but not with <z:chebi fb="3" ids="37445">folate</z:chebi> or <z:chebi fb="13" ids="33611">B12</z:chebi> levels </plain></SENT>
<SENT sid="2" pm="."><plain>Progression of WML (0.08 ± 0.16%) was not associated with <z:chebi fb="0" ids="17230">homocysteine</z:chebi> level (B = 0.01, p = 0.29) </plain></SENT>
<SENT sid="3" pm="."><plain>New SBIs were uncommon </plain></SENT>
<SENT sid="4" pm="."><plain>In older hypertensive individuals, plasma <z:chebi fb="0" ids="17230">homocysteine</z:chebi> levels are associated with increased rates of whole-brain <z:mpath ids='MPATH_127'>atrophy</z:mpath> but not WML progression </plain></SENT>
</text></document>